Immuno-, radio-, and chemotherapeutic studies in head and neck cancer. Highlights of the ASCO Annual Meeting 2017

被引：2

作者：

Schuler, P. J. ^{[1
]}

von Witzleben, A. ^{[1
]}

Doescher, J. ^{[1
]}

Wollenberg, B. ^{[2
]}

Dietz, A. ^{[3
]}

Hoffmann, T. K. ^{[1
]}

机构：

[1] Univ Klin Ulm, Klin Hals Nasen Ohrenheilkunde & Kopf Hals Chirur, Kopf Hals Tumorzentrum Ulm, Frauensteige 12, D-89070 Ulm, Germany

[2] Univ Klin Lubeck, Klin Hals Nasen Ohrenheilkunde & Kopf Hals Chirur, Kopf Hals Tumorzentrum Lubeck, Lubeck, Germany

[3] Univ Klin Leipzig, Klin Hals Nasen Ohrenheilkunde & Kopf Hals Chirur, Kopf Hals Tumorzentrum Leipzig, Leipzig, Germany

来源：

HNO | 2018年 / 66卷 / 03期

关键词：

Genome; Genetic structures; ASCO; Cell cyle checkpoints; Immunotherapy; SQUAMOUS-CELL CARCINOMA; RECURRENT;

D O I：

10.1007/s00106-018-0482-9

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

In recent years, immunotherapy has been shown to be a promising approach for the treatment of various tumor entities. Due to further pharmacological developments and new studies, the checkpoint inhibitors have now arrived in the clinic. To date, patients with cancers in the head and neck region have benefited from these agents as part of a palliative therapy. Current clinical trials are testing other indications for the checkpoint inhibitors as monotherapy or in combination with other therapeutic approaches. The following article summarizes the highlights of the American Society of Clinical Oncology (ASCO) Annual Meeting.

引用

页码：212 / 218

页数：7

共 40 条

[31] The most important study results concerning nonsurgical primary treatment of locally advanced head and neck cancer. Highlights of the ASCO Meeting 2015
Gliese, A.
Busch, C. -J.
Knecht, R.
HNO, 2015, 63 (09) : 606 - 611
[32] New aspects of HPV-positive head and neck cancer. Highlights from the 2011 ASCO Congress
Kofler, B.
Uecker, F. C.
Muenscher, A.
Knecht, R.
HNO, 2012, 60 (05) : 404 - 407
[33] Main results of studies on primary therapy of head and neck squamous cell carcinoma. Highlights of the ASCO Meeting 2014
Gliese, A.
Busch, C-J.
Knecht, R.
HNO, 2014, 62 (11) : 781 - 786
[34] Update zu HPV-assoziierten Kopf-Hals-Karzinomen – Highlights der ASCO-Jahrestagung 2018Update on HPV-associated head and neck cancer—highlights of the 2018 ASCO Annual Meeting
S. Tribius
N. Würdemann
S. Laban
S. J. Sharma
S. Wagner
T. K. Hoffmann
C. Wittekindt
J. P. Klussmann
HNO, 2018, 66 : 888 - 895
[35] Update zu HPV-assoziierten Kopf-Hals-Karzinomen – Highlights der ASCO-Jahrestagung 2019Update on HPV-associated head and neck cancer—highlights from the 2019 ASCO Annual Meeting
S. Tribius
N. Würdemann
S. Laban
T. K. Hoffmann
S. J. Sharma
J. P. Klussmann
HNO, 2019, 67 : 912 - 917
[36] Highlights der ASCO- und ESMO‑Jahrestagungen 2022: Strahlentherapie von Kopf‑Hals‑TumorenHighlights of the ASCO and ESMO annual meetings 2022: radiotherapy of head and neck cancer
Sören Schnellhardt
Maximilian Linxweiler
Antoniu-Oreste Gostian
Markus Hecht
HNO, 2023, 71 (7) : 446 - 452
[37] Strahlentherapeutische Studien bei Kopf-Hals-TumorenHighlights der ASCO-Jahrestagung 2019Studies on radiotherapy of head and neck cancerHighlights of the 2019 ASCO Annual Meeting
S. Ott
T. Wiegel
T. K. Hoffmann
C. Petersen
S. Tribius
S. Laban
HNO, 2019, 67 : 918 - 924
[38] Immuntherapeutische Studien bei Kopf-Hals-TumorenHighlights der ASCO-Jahrestagung 2016Immunotherapeutic studies of head and neck tumorsHighlights of the 2016 ASCO Annual Meeting
C.-J. Busch
S. Laban
R. Knecht
T. K. Hoffmann
HNO, 2016, 64 : 708 - 716
[39] Immuntherapie im Kontext anderer Therapiemodalitäten von Kopf-Hals-Tumoren – Highlights der ASCO- und ESMO-Jahrestagung 2022Immunotherapy in the context of other head and neck cancer treatment modalities—highlights of the ASCO and ESMO annual meeting 2022
Adrian von Witzleben
Thomas K. Hoffmann
Simon Laban
HNO, 2023, 71 : 440 - 445
[40] Highlights der ASCO- und ESMO-Jahrestagungen 2021 zur Strahlentherapie von Kopf-Hals-TumorenHighlights from the 2021 ASCO and ESMO annual meetings on radiotherapy of head and neck cancer
Markus Hecht
Jens von der Grün
Sabine Semrau
Sarina Müller
Thomas Weissmann
Udo S. Gaipl
Heinrich Iro
Rainer Fietkau
Antoniu-Oreste Gostian
HNO, 2022, 70 (4) : 258 - 264

← 1 2 3 4 →